KR20060103890A - 세네카 밸리 바이러스에 기초한 조성물 및 질병의 치료방법 - Google Patents

세네카 밸리 바이러스에 기초한 조성물 및 질병의 치료방법 Download PDF

Info

Publication number
KR20060103890A
KR20060103890A KR1020067008081A KR20067008081A KR20060103890A KR 20060103890 A KR20060103890 A KR 20060103890A KR 1020067008081 A KR1020067008081 A KR 1020067008081A KR 20067008081 A KR20067008081 A KR 20067008081A KR 20060103890 A KR20060103890 A KR 20060103890A
Authority
KR
South Korea
Prior art keywords
virus
svv
cells
mutant
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020067008081A
Other languages
English (en)
Korean (ko)
Inventor
폴 엘 할렌벡
칼 엠 헤이
샨티 게인쉬
세쉬다 레디 폴리스
링 슈
징핑 양
쳉 쳉
Original Assignee
노바르티스아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노바르티스아게 filed Critical 노바르티스아게
Publication of KR20060103890A publication Critical patent/KR20060103890A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32061—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020067008081A 2003-09-26 2004-09-23 세네카 밸리 바이러스에 기초한 조성물 및 질병의 치료방법 Withdrawn KR20060103890A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50618203P 2003-09-26 2003-09-26
US60/506,182 2003-09-26

Publications (1)

Publication Number Publication Date
KR20060103890A true KR20060103890A (ko) 2006-10-04

Family

ID=34393123

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067008081A Withdrawn KR20060103890A (ko) 2003-09-26 2004-09-23 세네카 밸리 바이러스에 기초한 조성물 및 질병의 치료방법

Country Status (12)

Country Link
EP (1) EP1668025B1 (cg-RX-API-DMAC7.html)
JP (1) JP2007506434A (cg-RX-API-DMAC7.html)
KR (1) KR20060103890A (cg-RX-API-DMAC7.html)
CN (1) CN1875028B (cg-RX-API-DMAC7.html)
AU (1) AU2004275832A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0414810A (cg-RX-API-DMAC7.html)
CA (1) CA2540177A1 (cg-RX-API-DMAC7.html)
DK (1) DK1668025T3 (cg-RX-API-DMAC7.html)
IL (1) IL174430A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA06003318A (cg-RX-API-DMAC7.html)
SG (1) SG149069A1 (cg-RX-API-DMAC7.html)
WO (1) WO2005030139A2 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ425699A0 (en) 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
AU2002953436A0 (en) 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
US7638318B2 (en) 2003-09-26 2009-12-29 Norvartis Ag Seneca Valley virus based compositions and methods for treating disease
WO2007047256A2 (en) * 2005-10-13 2007-04-26 Neotropix, Inc. Svv-based animal vaccines and uses thereof
WO2017096201A1 (en) 2015-12-02 2017-06-08 Memorial Sloan-Kettering Cancer Center Seneca valley virus (svv) cellular receptor targeted oncotherapy
CN105925728B (zh) * 2016-06-01 2019-09-20 华南农业大学 一种塞内加谷病毒实时荧光定量pcr检测引物及试剂盒
US10323069B2 (en) * 2016-08-23 2019-06-18 Regents Of The University Of Minnesota Senecavirus A antigens and methods of use
RU2020106730A (ru) * 2017-07-14 2021-08-16 Онкорус, Инк. Инкапсулированные полинуклеотиды и способы их применения
CN109627293B (zh) * 2017-08-13 2021-02-09 中牧实业股份有限公司 塞尼卡谷病毒结构蛋白抗原表位多肽及其应用
CN107513524B (zh) * 2017-09-30 2021-02-09 中牧实业股份有限公司 一株猪塞内加谷病毒毒株及其应用
CN108467904B (zh) * 2018-05-24 2021-11-19 华南农业大学 检测塞尼卡谷病毒的rt-lamp引物组、试剂盒及应用
CN109182278B (zh) * 2018-10-12 2021-08-06 河南省动物疫病预防控制中心 塞尼卡谷病毒毒株及其应用
CA3117924A1 (en) * 2018-11-13 2020-05-22 Oncorus, Inc. Encapsulated polynucleotides and methods of use
CN109234464A (zh) * 2018-11-23 2019-01-18 山东新希望六和集团有限公司 用于检测塞尼卡谷病毒的引物及探针、荧光定量pcr试剂盒及方法和应用
CN111733144A (zh) * 2019-03-25 2020-10-02 金宇保灵生物药品有限公司 一种塞内卡病毒的纯化方法及病毒液的浓缩纯化方法
CN110229218B (zh) * 2019-06-24 2020-12-01 中国动物疫病预防控制中心(农业农村部屠宰技术中心) 检测塞内卡病毒抗体的试剂及其所用多肽
WO2021016194A1 (en) * 2019-07-19 2021-01-28 Racaniello Vincent R Second generation seneca valley virus oncolytic therapy: compositions and methods thereof
CN110923211A (zh) * 2019-12-25 2020-03-27 哈药集团生物疫苗有限公司 塞内卡病毒分离株、塞内卡病毒病灭活疫苗及其制备方法
CN111286491A (zh) * 2020-02-03 2020-06-16 河南省动物疫病预防控制中心 猪塞内卡病毒核酸标准物及其应用
CN111849925B (zh) * 2020-07-06 2022-06-03 马忠仁 一种抗结肠癌疫苗及其制法
CN111798712B (zh) * 2020-07-15 2021-10-29 周晓庆 噬菌体侵染细菌3d智能模拟方法
CN111944764A (zh) * 2020-08-31 2020-11-17 信阳农林学院 一种表达猪塞内加谷病毒蛋白的细胞系、构建方法和应用
CN112390861A (zh) * 2020-09-30 2021-02-23 信阳农林学院 表达猪塞内加谷病毒vp1蛋白的细胞系、构建方法和应用
CN117281824B (zh) * 2023-08-11 2025-10-21 华南农业大学 Trim基因的过表达剂在制备抑制猪塞内卡病毒复制的产品中的应用
CN117487006B (zh) * 2023-12-29 2024-04-12 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心) 一种抗a型塞内卡病毒的单克隆抗体以及抗原表位及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110461A (en) * 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia

Also Published As

Publication number Publication date
HK1094583A1 (en) 2007-04-04
BRPI0414810A (pt) 2006-11-14
JP2007506434A (ja) 2007-03-22
WO2005030139A2 (en) 2005-04-07
CN1875028B (zh) 2012-07-04
EP1668025A4 (en) 2007-05-16
AU2004275832A1 (en) 2005-04-07
EP1668025A2 (en) 2006-06-14
IL174430A0 (en) 2006-08-01
SG149069A1 (en) 2009-01-29
CA2540177A1 (en) 2005-04-07
CN1875028A (zh) 2006-12-06
WO2005030139A3 (en) 2005-10-20
MXPA06003318A (es) 2006-06-08
DK1668025T3 (da) 2014-08-25
EP1668025B1 (en) 2014-06-25

Similar Documents

Publication Publication Date Title
US8039606B2 (en) Seneca Valley virus based compositions and methods for treating disease
CN1875028B (zh) 基于 Seneca Valley 病毒的组合物以及疾病的治疗方法
US7670598B2 (en) Method for limiting the growth of cancer cells using an attenuated measles virus
US20120328575A1 (en) Modified Oncolytic Viruses
US12521424B2 (en) Optimized oncolytic viruses and uses thereof
Liu et al. RETRACTED ARTICLE: Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
CN109276580A (zh) 一种用于治疗肿瘤的病毒
CN101448526A (zh) 基于西尼加谷病毒的组合物和治疗疾病的方法
HK1094583B (en) Seneca valley virus based compositions and methods for treating disease
AU2004202292B2 (en) Method of Treating a Malignancy in a Subject
WO2007047256A2 (en) Svv-based animal vaccines and uses thereof
McCarthy Thermal Selection of Seneca Valley Virus Gives Rise to a Novel Thermostable Mutant
Poirier Preclinical and clinical studies of Seneca Valley Virus, a therapeutically promising oncolytic picornavirus with neuroendocrine tropism
AU2011204997A1 (en) A method of treating a malignancy in a subject and a pharmaceutical composition for use in same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060426

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid